// App-Quantinova.ai

4025 : Impact of Kras mutant subtypes on PD-L1 expression in lung adenocarcinoma

Researchers

Presenter

  • Marius Ilie

Principal Investigators

  • Laetitia Fazzalari

  • Nicolas Guibert

  • Nathalie Yazbeck

  • Laurie Signetti

  • Veronique Hofman

  • Elodie Long

  • Katia Zahaf

  • Julien Fayada

  • Virginie Lespinet

  • Olivier Bordone

  • Virginie Tanga

  • Kevin Washetine

  • Nicolas Venissac

  • Jerome Mouroux

  • Charles Hugo Marquette

  • Patrick Brest

  • Paul Hofman

Medical Centers

  • CHU de Nice, Laboratory of Clinical and Experimental Pathology, Nice, France

  • Institute for Research on Cancer and Aging, Nice (IRCAN), University of Nice Sophia Antipolis, Nice, France

  • Universite Paul Sabatier, CHU Toulouse, Thoracic Oncology Unit, Toulouse, France

  • CHU de Nice, Thoracic Surgery Department, Nice, France

  • CHU de Nice, Pneumology Department, Nice, France.

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved